AI assistant
IRADIMED CORP — Director's Dealing 2021
Dec 1, 2021
32324_dirs_2021-11-30_1c87233c-40df-4b04-9992-7b6330560ba0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2021-11-26
Reporting Person: HAWKINS JAMES B (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-26 | Common Stock | A | 4332 | $1.48 | Acquired | 21600 | Direct |
| 2021-11-26 | Common Stock | S | 4332 | $44 | Disposed | 17268 | Direct |
| 2021-11-29 | Common Stock | A | 12176 | $1.48 | Acquired | 29444 | Direct |
| 2021-11-29 | Common Stock | S | 12176 | $46.11 | Disposed | 17268 | Direct |
| 2021-11-30 | Common Stock | A | 1257 | $1.48 | Acquired | 18525 | Direct |
| 2021-11-30 | Common Stock | S | 1257 | $46.2309 | Disposed | 17268 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-26 | Stock Options (Right to Buy) | $1.48 | M | 4332 | Disposed | 2023-12-31 | Common Stock (4332) | Direct |
| 2021-11-29 | Stock Options (Right to Buy) | $1.48 | M | 12176 | Disposed | 2023-12-31 | Common Stock (12176) | Direct |
| 2021-11-30 | Stock Options (Right to Buy) | $1.48 | M | 1257 | Disposed | 2023-12-31 | Common Stock (1257) | Direct |
Footnotes
F1: This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
F2: This transaction was executed in multiple trades at prices ranging from $44.44 to $46.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $46.20 to $46.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.